We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$7.07M
(+6.8%)
Cap. Flow
+$1.09M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
131
New
20
Increased
38
Reduced
36
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPS Commerce
SPSC
|
+$1.13M |
| 2 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
+$1.04M |
| 3 |
IVTY
Invuity, Inc
IVTY
|
+$996K |
| 4 |
TTSH
Tile Shop Holdings
TTSH
|
+$902K |
| 5 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$692K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$2.02M |
| 2 |
AbbVie
ABBV
|
+$1.96M |
| 3 |
Integer Holdings
ITGR
|
+$1.45M |
| 4 |
CGNT
Cogentix Medical, Inc.
CGNT
|
+$1.37M |
| 5 |
Altria Group
MO
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.99% |
| 2 | Technology | 12.75% |
| 3 | Industrials | 9.54% |
| 4 | Energy | 4.99% |
| 5 | Financials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-12,325
| Closed | -$234K |
|
127
US Gold Corp
USAU
$214M
| – | – |
-5,800
| Closed | -$95K |
|
|
MMAT
128
DELISTED
Meta Materials Inc. Common Stock
MMAT
| – | – |
-358
| Closed | -$96K |
|
|
CASC
129
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-35,632
| Closed | -$132K |
|
|
TEAR
130
DELISTED
TearLab Corporation
TEAR
| – | – |
-1,553,383
| Closed | -$598K |
|
|
DGLT
131
DELISTED
Digiliti Money Group, Inc. Common Stock
DGLT
| – | – |
-27,778
| Closed | -$3K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Perkins Capital Management held 131 positions worth $111M, up 6.8% from $104M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Perkins Capital Management's Q1 2018 filing shows 20 new, 38 increased, 36 reduced and 14 closed positions. Its largest new stake was SPS Commerce: 40,000 shares worth $1.28M. The largest sale was Axogen, an estimated $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q1 2018 buy was SPS Commerce: 40,000 shares worth $1.28M.
- Perkins Capital Management added most to Craft Brew Alliance, Inc. in Q1 2018, an estimated $568K increase.
- Perkins Capital Management's biggest Q1 2018 reduction was Axogen, cutting an estimated $2.02M.
- Perkins Capital Management fully exited AbbVie in Q1 2018, selling an estimated $1.96M.
- Perkins Capital Management's ten largest holdings make up 37% of its $111M portfolio in Q1 2018.
- Perkins Capital Management opened 20 new positions and closed 14 in Q1 2018.
- Perkins Capital Management's portfolio value rose 6.8% quarter-over-quarter to $111M.
Based on Perkins Capital Management's 13F filing for Q1 2018, filed 23 Apr 2018.